Reports Q3 revenue $2.91B, consensus $2.72B. “We are pleased with the broad-based strength in revenue and earnings growth across Pharmacy Solutions and Providers Services in Q3,” said CEO Jon Rousseau. “At BrightSpring we are focused on driving operational excellence and efficiencies while increasing scale across our organization to deliver lower-cost and high-quality care to patients. We are confident that the Company remains well positioned to execute on providing a high level of quality care to patients and continuing to grow our businesses for the remainder of 2024 and in 2025.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health Services, Inc. (BTSG) Q3 Earnings Cheat Sheet
- BrightSpring Health’s Chief Legal Officer Announces Retirement Plan
- BrightSpring Health initiated with a Sector Weight at KeyBanc
- BrightSpring Health price target raised to $20 from $15 at BTIG
- BrightSpring Health price target raised to $18 from $15 at Guggenheim